SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Brad who wrote (1361)7/22/1998 11:50:00 AM
From: Chuck Rubin  Read Replies (1) | Respond to of 4650
 
Brad,

Thank you very much for that info. With your help and that phone conversation you had with Mr. Ma'ayan we may be well on our way to resolving some of these questions and making sense of some of the seeming miscommunication.
I am glad he said he would talk with Mr. Robins.
Sounds very credible that maybe ADOT did have certain agreements with the previous CEO of Biomoda, that would make lots of sense, hopefully that will be clarified.
And the warrants bringing ADOT to 27% share of Biomoda at their option would clarify that point of share ownership.
I think you did a great job with this phone conversation.

Chuckr




To: Brad who wrote (1361)7/23/1998 2:51:00 PM
From: thomas alta  Respond to of 4650
 
BIOMODA TECHNOLOGY fo read cervical pap. cannot be over looked Woman get many more cervical paps to rule out uterine cancer in there life time then sputum paps. To be able to read a paps with an insturtment is big news.It removes the fallablity of a technicin and is suppose to be more accurate. Any medical man who get a false negative is just very upset---tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News